CLINICAL ROLE -
Breakthrough Cancer Treatment Highlights Specialty Pharmacy Week in Review
Top stories of the week on Specialty Pharmacy Times from May 11 to May 15.
Read More
Black Men Have Significantly Higher Rates of Male Breast Cancer Mortality
Black men more likely to be diagnosed with breast cancer at a younger age than white men.
Specialty Pharmacy and the Affordable Care Act
National Association of Specialty Pharmacy (NASP) Executive Director James E. Smeeding, RPh, MBA, discusses the impact of the Affordable Care Act on specialty pharmacy.
The Impact from the Economic Burden of Cancer on Survivorship
Excess medical expenses, employment disability, and a drop in production at work common in cancer survivors.
Generic Transplant Drugs as Effective as Brand Name Treatment
Promising results from generic formulation of drug used post-transplant to reduce the risk of organ rejection.
Quick Approval of High Cost Cancer Drugs Don't Benefit Patients
Study warns that drug reviewers don't look at long term survival of patients.
Interferon-Free Therapy Shows High Cure Rates in Hepatitis C Patients with Cirrhosis
Investigational 3-drug combination cleared the virus in 93% of treatment-naïve patients.
Silicon Microparticles Dramatically Boost Efficacy of Breast Cancer Vaccines
Particles protected antigen from premature destruction and prompted the immune system to attack cancer cells.
Hepatitis C Drug Combination Shows Strong Efficacy With or Without Cirrhosis
Direct-acting-antiviral drugs daclatasvir, asunaprevir, and beclabuvir showed high rates of sustained virologic response after 12 weeks.
Various Factors Cause Hot Flashes in Prostate Cancer Patients
Age and weight found to play a role in side effects.
The Road Ahead for Cancer Care
Kjel Jonhson, PharmD, Vice President of Global Oncology for IMS Health, discusses changes in store for the care of cancer patients over the next decade.
Discovery May Speed Up Targeted Cancer Therapy
Mass spectrometry reveals all proteins that repair damaged cancer DNA.
New Combination Strategy Shows Promise in Glioblastoma Treatment
Targeting gene mutations causes stress that damages cancer cell DNA.
Combination of Chemotherapy and Immunotherapy Shows Promise in Prostate Cancer
Treating immune-suppressing cells allows for destruction of tumors.
Alcohol Use Disorder Stronger Predictor of Mortality than Hepatitis C Infection
Study finds chronic hepatitis C has a limited impact on mortality unless the patient has other severe comorbidities.
Drug Recall, Generic Bone Cancer Medication Launch Highlights Specialty Pharmacy Week in Review
A look back at the top stories on Specialty Pharmacy Times from May 4 to May 8.
Subdermal Implant Delivers Potent HIV Therapy
Implant delivers sustained release of ARV drugs up to 40 days with no adverse side effects.
Telomerase-Inhibition May Change Cancer Treatment
Genetically determined telomere length may not influence mortality.
Extended Hemophilia Treatment Safe and Effective in Children
Combination of recombinant factor VIII with a fusion protein allows for less frequent treatment.
Diet Effects Colon Cancer Risk
Diets with more animal protein and less soluble fiber increases cancer risk.
Lung Cancer Mortality May be Lowered by Long-Term Statin Use
Researchers find significant reduction in lung cancer-specific deaths.
Hepatitis C Increases Likelihood of Cancer Diagnosis
Cancer rates significantly greater compared with non-infected individuals.
Vaccine Enhances Effect of HIV Drugs
Boosting immune system improves efficacy of antiretroviral drugs.
Delaying Hepatitis C Treatment Increases Death Risk
Delays can negatively affect treatment efficacy and the risk of morbidity and mortality among patients.
Breakthrough Hepatitis C Drug Highlights Specialty Pharmacy Week in Review
A look back at the top stories of the week on Specialty Pharmacy Times from April 27 to May 1.
Treatment May Prevent Development of Multiple Sclerosis
Blocking production of specific immune cell protects against onset of MS.
Sofosbuvir/Daclatasvir Combination Effective in Hepatitis C Treatment
Therapy shows promise in treatment of hepatitis C genotype-1 mono-infected patients.
Health Insurance Coverage for Cancer Varies by Demographics, Cancer Type
Highest uninsured rates found in patients with testicular, stomach, and cervical cancers.
New Drugs Fight Root Cause of Multiple Sclerosis
Two new drugs showed significant reversal of disease severity.